Literature DB >> 8054266

Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.

A Merzak1, S McCrea, S Koocheckpour, G J Pilkington.   

Abstract

Factors involved in the control of the biological properties of gliomas, the major form of brain tumour in man, are poorly documented. We investigated the role of transforming growth factor beta 1 (TGF-beta 1) in the control of proliferation of human glioma cell lines as well as normal human fetal brain cells. The data presented show that TGF-beta 1 exerts a growth-inhibitory action on both human fetal brain cells and three cell lines derived from human glioma of different grades of malignancy. In addition, this growth-inhibitory effect is dose dependent and serum independent. Since TGF-beta 1 is known to be involved in the control of cell migration during ontogenesis and oncogenesis, we investigated the role of this factor in the motile and invasive behaviour that characterises human gliomas in vivo. TGF-beta 1 was found to elicit a strong stimulation of migration and invasiveness of glioma cells in vitro. In combination with recent data showing an inverse correlation between TGF-beta 1 expression in human gliomas and survival, these findings may suggest that TGF-beta 1 plays an important role in the malignant progression of gliomas in man. A study of the molecular mechanisms involved in the antiproliferative action and the invasion-promoting action of TGF-beta 1 may help to identify new targets in therapy for brain tumours. A combined antiproliferative and anti-invasive therapy could be envisaged.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054266      PMCID: PMC2033507          DOI: 10.1038/bjc.1994.280

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Serum and transforming growth factor beta regulate glial fibrillary acidic protein in serum-free-derived mouse embryo cells.

Authors:  Y Sakai; C Rawson; K Lindburg; D Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  A rapid in vitro assay for quantitating the invasive potential of tumor cells.

Authors:  A Albini; Y Iwamoto; H K Kleinman; G R Martin; S A Aaronson; J M Kozlowski; R N McEwan
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

3.  Chemotaxis of rat brain astrocytes to platelet derived growth factor.

Authors:  J P Bressler; G R Grotendorst; C Levitov; L M Hjelmeland
Journal:  Brain Res       Date:  1985-10-07       Impact factor: 3.252

Review 4.  Peptide growth factors are multifunctional.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

5.  New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

6.  Developmental expression of transforming growth factors alpha and beta in mouse fetus.

Authors:  J N Wilcox; R Derynck
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

7.  Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain.

Authors:  J N Wilcox; R Derynck
Journal:  J Neurosci       Date:  1988-06       Impact factor: 6.167

8.  Transforming growth factor type beta 1 modulates the effects of basic fibroblast growth factor on growth and phenotypic expression of rat astroblasts in vitro.

Authors:  G Labourdette; T Janet; P Laeng; F Perraud; D Lawrence; B Pettmann
Journal:  J Cell Physiol       Date:  1990-09       Impact factor: 6.384

9.  Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.

Authors:  R de Martin; B Haendler; R Hofer-Warbinek; H Gaugitsch; M Wrann; H Schlüsener; J M Seifert; S Bodmer; A Fontana; E Hofer
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  A role for TGF-beta in oligodendrocyte differentiation.

Authors:  R D McKinnon; G Piras; J A Ida; M Dubois-Dalcq
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

View more
  39 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 2.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

3.  Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.

Authors:  Peter Hau; Leoni A Kunz-Schughart; Petra Rümmele; Füsun Arslan; Anett Dörfelt; Horst Koch; Annette Lohmeier; Birgit Hirschmann; Adolf Müller; Ulrich Bogdahn; Anja-Katrin Bosserhoff
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

4.  Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.

Authors:  Mengxian Zhang; Tobias W Herion; Carmen Timke; Na Han; Kai Hauser; Klaus J Weber; Peter Peschke; Ute Wirkner; Michael Lahn; Peter E Huber
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

5.  Medulloblastoma displays distinct regional matrix metalloprotease expression.

Authors:  G H Vince; C Herbold; R Klein; J Kühl; T Pietsch; S Franz; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 6.  Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Authors:  W Wick; M Platten; M Weller
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 7.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

8.  Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.

Authors:  Vineet Sangar; Cory C Funk; Ulrike Kusebauch; David S Campbell; Robert L Moritz; Nathan D Price
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

9.  S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.

Authors:  Ran Xie; Matthew P Schlumbrecht; Gregory L Shipley; Susu Xie; Roland L Bassett; Russell R Broaddus
Journal:  Lab Invest       Date:  2009-06-08       Impact factor: 5.662

10.  Glioblastoma Multiforme Oncogenomics and Signaling Pathways.

Authors:  Okezie O Kanu; Betsy Hughes; Chunhui Di; Ningjing Lin; Jinrong Fu; Darell D Bigner; Hai Yan; Cory Adamson
Journal:  Clin Med Oncol       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.